Starpax Biopharma Revenue
Biotechnology Research • 
Montreal, Quebec, Canada • 11-20 Employees
Starpax Biopharma revenue & valuation
| Annual revenue | $1,283,325 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,200,000 |
| Total funding | No funding |
Key Contacts at Starpax Biopharma
Marie-Estelle Page-Clisson
Director, Biopharmaceutical Development
Charles Tremblay
Medical Technology Director
Company overview
| Headquarters | 1100, boul. René-Lévesque Ouest, 25e étage, Montréal, QC H3B 5C9, CA |
| Website | |
| NAICS | 541714 |
| Keywords | Biotechnology, Oncology, Medical Device, Drug Delivery, Biopharmaceuticals, Cancer Treatment, Cancer Stem Cell Treatment |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
Starpax Biopharma Email Formats
Starpax Biopharma uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@starpaxbiopharma.com), used 57.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@starpaxbiopharma.com | 57.1% |
{first initial}{last name} | jdoe@starpaxbiopharma.com | 42.9% |
About Starpax Biopharma
Starpax Biopharma Inc. has developed a novel Precision 3D Guidance Therapy of Magnetodrones™ in tumors. Magnetodrones™ are unique medication-bearing bacteria, developed by Starpax™, that are sensitive to magnetic fields. They deliver the medication into the mass of the tumour, without allowing the medication to circulate in the bloodstream. At the same time, the Magnetodrones™ saturate hypoxic areas where cancerous cells are difficult to reach with other treatments. Magnetodrones are injected directly into the tumour and are guided by the PolarTrak device, in which the patient is positioned. The PolarTrak™ prevents the Magnetodrones™ from leaving the tumour and guides them in 3D with special magnetic fields. Starpax Biopharma inc. a développé une thérapie inédite de guidage de précision 3D de Magnétodrones™ dans les tumeurs.. Les Magnétodrones™ sont des bactéries uniques développées par Starpax, sensibles aux champs magnétiques, sur lesquelles sont attachés les médicaments à leur surface. Les Magnétodrones™ distribuent des médicaments dans la masse des tumeurs sans circuler dans le réseau sanguin, tout en saturant les zones hypoxiques où les cellules cancéreuses sont difficiles à atteindre par le biais d’autres traitements. Les Magnétodrones™ sont injectés directement dans la tumeur et guidés par l’appareil PolarTrak™, où le patient est installé. Le PolarTrak™ empêche les Magnétodrones™ de sortir de la tumeur et les guide en 3D grâce à ses champs magnétiques spéciaux.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Starpax Biopharma has 5 employees across 3 departments.
Departments
Number of employees
Funding Data
Starpax Biopharma has never raised funding before.
Starpax Biopharma Tech Stack
Discover the technologies and tools that power Starpax Biopharma's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
WordPress plugins
JavaScript libraries
Page builders
JavaScript libraries
CDN
Web servers
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
United States
France
Venezuela, Bolivarian Republic of
Frequently asked questions
4.8
40,000 users
